Solid phase synthesis of an extensively focused library of thiadiazole ethers

Tetrahedron

Volumn 60, Issue 39, 2004, Pages 8627-8632

  Pernerstorfer, Josef ^a   Brands, Michael ^a   Schirok, Hartmut ^a   Stelte Ludwig, Beatrix ^a   Woltering, Elisabeth ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Extensively focused libraries; Parallel synthesis; Solid phase synthesis; Sulfones; Thiadiazoles

Indexed keywords

2,5 BIS(METHYLSULFONYL) 1,3,4 THIADIAZOLE; 4 [[[5 (2 ETHOXYPHENOXY) 1,3,4 THIADIAZOL 2 YL]SULFONYL]METHYL] N (4 FLUOROPHENYL)BENZAMIDE; N (4 FLUOROPHENYL) 4 [[(5 PHENOXY 1,3,4 THIADIAZOL 2 YL)SULFONYL]METHYL] BENZAMIDE; N (4 FLUOROPHENYL) 4 [[[5 (1 NAPHTHYLOXY) 1,3,4 THIADIAZOL 2 YL]SULFONYL]METHYL]BENZAMIDE; THIADIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; DRUG POTENCY; DRUG SYNTHESIS; OXIDATION KINETICS; PRIORITY JOURNAL; SOLID STATE; SUBSTITUTION REACTION;

EID: 4344595258     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2004.05.103     Document Type: Article

References (12)

1. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P. J. Adv. Drug Deliv. Rev. 23:1997;3-25
2. Teague S.J., Davies A.M., Leeson P.D., Oprea T. Angew. Chem. 111:1999;3962-3967
3. Lewell X.Q., Judd D.B., Watson S.P., Hann M.M. J. Chem. Inf. Comput. Sci. 38:1998;511-522
4. Song Y., Connor D.T., Sercel A.D., Sorenson R.J., Doubleday R., Unangst P.C., Roth B.D., Beylin V.G., Gilbertsen R.B., Chan K., Schrier D.J., Guglietta A., Bornemeier D.A., Dyer R.D. J. Med. Chem. 42:1999;1161-1169
5. Antonaroli S., Bianco A., Brufani M., Cellai L., Baido G.L., Potier E., Bonomi L., Perfetti S., Fiaschi A.I., Segre G. J. Med. Chem. 35:1992;2697-2703
6. Kariyone K., Harada H., Kurita M., Takano T. J. Antibiot. 23:1970;131-148
7. Sassiver M.L., Shepherd R.G. J. Med. Chem. 9:1966;541-545
8. Xiao X.-Y., Li R., Zhuang H., Ewing B., Karunaratne K., Lillig J., Brown R., Nicolaou K.C. Biotechnol. Bioeng. (Comb. Chem.). 71:2000;33-45
9. Vinod T.K., Hart H. J. Org. Chem. 56:1991;5630-5640
10. It was not elucidated whether substitution took place from the 4-pyridol tautomer which gives 4-(1,3,4-thiadiazol-2-yloxy)pyridine or from the 4-pyridone tautomer to give the 1-(1,3,4-thiadiazol-2-yl)pyridin-4(1H)-one
11. For detailled description of in vitro assay, see Brands, M.; Grützmann, R.; Kalthoff, B.; Keldenich, J.; Lang, D.; Müller, U.; Pernerstorfer, J.; Raabe, M.; Rank, E.; Schirok, H.; Schmeck, C.; Schuhmacher, J.; Stelte-Ludwig, B.; Urbahns, K.; Zaiss, S. GB 2380190, 2003.
12. Thorn G.D. Can. J. Chem. 38:1960;1439-1444